FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2885872617> ?p ?o ?g. }

• W2885872617 endingPage "1332" @default.
• W2885872617 startingPage "1295" @default.
• W2885872617 abstract "Tumor necrosis factor (TNF) inhibitors are widely used biologics for the treatment of several chronic inflammatory diseases. The launch of anti-TNF biosimilars has introduced the possibility of non-medical switching between originator biologics and their biosimilars. However, the potential clinical and patient-reported consequences of non-medical switching remain largely unknown, as much of the evidence comes from poorly or uncontrolled real-world evidence (RWE) studies that often have an element of bias and nonstandardized outcome measures. To appropriately evaluate the safety, efficacy, and immunogenicity of non-medical switching from an originator to its biosimilar, we propose that seven key study design elements should be considered when assessing the existing evidence: studies should be (1) randomized and double-blind, (2) adequately controlled, and (3) adequately powered; include (4) multiple switching, (5) an assessment of immunogenicity, and (6) adequate follow-up duration; and (7) report individual patient-level outcomes. This systematic review assessed the robustness and consistency of the current non-medical switching evidence, with a focus on TNF inhibitors. A comprehensive literature search (January 2012-February 2018) identified 98 publications corresponding to 91 studies (17 randomized controlled trials and 74 RWE studies) describing non-medical switching from a TNF inhibitor originator to its biosimilar. When assessing the totality of this evidence, none of the non-medical switching studies conducted to date were found to use all seven of the key design elements, and the absence of these elements dilutes the robustness of the data. Furthermore, discontinuation rates varied widely among studies (0-87%), suggesting heterogeneity and inconclusiveness of the current efficacy, safety, and immunogenicity evidence, particularly at an individual patient level. Therefore, patients should not be indiscriminately switched from an originator TNF inhibitor to its biosimilar for non-medical reasons. Switching decisions should remain between the treating physicians and their patients and be made on a case-by-case basis, relying upon robust scientific evidence.AbbVie.Plain Language Summary: Plain language summary available for this article." @default.
• W2885872617 created "2018-08-22" @default.
• W2885872617 creator A5024989397 @default.
• W2885872617 creator A5025426073 @default.
• W2885872617 date "2018-08-06" @default.
• W2885872617 modified "2023-10-05" @default.
• W2885872617 title "Non-medical Switching from Originator Tumor Necrosis Factor Inhibitors to Their Biosimilars: Systematic Review of Randomized Controlled Trials and Real-World Studies" @default.
• W2885872617 cites W1594887498 @default.
• W2885872617 cites W1827882046 @default.
• W2885872617 cites W1954244899 @default.
• W2885872617 cites W1965138135 @default.
• W2885872617 cites W1971610012 @default.
• W2885872617 cites W2022888597 @default.
• W2885872617 cites W2028465542 @default.
• W2885872617 cites W2106152050 @default.
• W2885872617 cites W2106962952 @default.
• W2885872617 cites W2121050884 @default.
• W2885872617 cites W2130173462 @default.
• W2885872617 cites W2144831942 @default.
• W2885872617 cites W2162768160 @default.
• W2885872617 cites W2279977120 @default.
• W2885872617 cites W2317502128 @default.
• W2885872617 cites W2321566470 @default.
• W2885872617 cites W2333956343 @default.
• W2885872617 cites W2342216265 @default.
• W2885872617 cites W2342464058 @default.
• W2885872617 cites W2342581896 @default.
• W2885872617 cites W2345220764 @default.
• W2885872617 cites W2403558607 @default.
• W2885872617 cites W2407658018 @default.
• W2885872617 cites W2412734069 @default.
• W2885872617 cites W2414751009 @default.
• W2885872617 cites W2478788944 @default.
• W2885872617 cites W2482832580 @default.
• W2885872617 cites W2495543595 @default.
• W2885872617 cites W2508045778 @default.
• W2885872617 cites W2521883132 @default.
• W2885872617 cites W2526345971 @default.
• W2885872617 cites W2543281533 @default.
• W2885872617 cites W2550409100 @default.
• W2885872617 cites W2550699063 @default.
• W2885872617 cites W2551989327 @default.
• W2885872617 cites W2555761630 @default.
• W2885872617 cites W2578994901 @default.
• W2885872617 cites W2581281042 @default.
• W2885872617 cites W2581549770 @default.
• W2885872617 cites W2581934257 @default.
• W2885872617 cites W2584947097 @default.
• W2885872617 cites W2586796756 @default.
• W2885872617 cites W2587002986 @default.
• W2885872617 cites W2587065878 @default.
• W2885872617 cites W2587349861 @default.
• W2885872617 cites W2587412299 @default.
• W2885872617 cites W2587493185 @default.
• W2885872617 cites W2593211227 @default.
• W2885872617 cites W2593580677 @default.
• W2885872617 cites W2593923237 @default.
• W2885872617 cites W2606512646 @default.
• W2885872617 cites W2606518498 @default.
• W2885872617 cites W2607057175 @default.
• W2885872617 cites W2607074221 @default.
• W2885872617 cites W2610308940 @default.
• W2885872617 cites W2613299853 @default.
• W2885872617 cites W2619695022 @default.
• W2885872617 cites W2623521568 @default.
• W2885872617 cites W2623636343 @default.
• W2885872617 cites W2624289061 @default.
• W2885872617 cites W2626689945 @default.
• W2885872617 cites W2663689705 @default.
• W2885872617 cites W2733382837 @default.
• W2885872617 cites W2733544055 @default.
• W2885872617 cites W2741340135 @default.
• W2885872617 cites W2748407913 @default.
• W2885872617 cites W2751387666 @default.
• W2885872617 cites W2751921355 @default.
• W2885872617 cites W2752226981 @default.
• W2885872617 cites W2753152387 @default.
• W2885872617 cites W2753659503 @default.
• W2885872617 cites W2759349664 @default.
• W2885872617 cites W2764082441 @default.
• W2885872617 cites W2765150986 @default.
• W2885872617 cites W2765264619 @default.
• W2885872617 cites W2765667082 @default.
• W2885872617 cites W2765963839 @default.
• W2885872617 cites W2766388803 @default.
• W2885872617 cites W2766795500 @default.
• W2885872617 cites W2767179430 @default.
• W2885872617 cites W2770163461 @default.
• W2885872617 cites W2774116866 @default.
• W2885872617 cites W2784409714 @default.
• W2885872617 cites W2786897800 @default.
• W2885872617 cites W2787443244 @default.
• W2885872617 cites W2794339583 @default.
• W2885872617 cites W2795103548 @default.
• W2885872617 cites W2799534621 @default.
• W2885872617 cites W2898096328 @default.
• W2885872617 cites W4246739685 @default.
• W2885872617 doi "https://doi.org/10.1007/s12325-018-0742-9" @default.

• next